Atherosclerosis: The emerging role of inflammation and the CD40–CD40 ligand system
Open Access
- 20 June 2000
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 97 (13) , 6930-6932
- https://doi.org/10.1073/pnas.97.13.6930
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Requirement for CD154 in the progression of atherosclerosisNature Medicine, 1999
- Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic LesionsThe American Journal of Pathology, 1999
- Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable AnginaCirculation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- CD40 signaling in vascular cells: A key role in atherosclerosis?Atherosclerosis, 1998
- Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40–CD40 ligand signaling in atherosclerosisProceedings of the National Academy of Sciences, 1997
- CD40 and Its Ligand in Host DefenseImmunity, 1996
- CD40 Expression by human fibroblastsClinical Immunology and Immunopathology, 1995
- Prevention of Collagen-Induced Arthritis with an Antibody to gp39, the Ligand for CD40Science, 1993